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            Resin composites (RC) are widely used due to increases in esthetic demand and 
increased concerns about mercury toxicity. Dentists choose RC because of the 
conservative approach of this preparation when compared with amalgam restorations. 
Mechanical properties of these restorations are improving continuously through ongoing 
research in this area. Unfortunately, much research is still needed to test the 
biocompatibility of these materials and their biological behavior. Cytotoxicity tests done 
in vitro and in vivo have shown that there are monomers that leach from the RC and that 
can cause cell death and damage to the surrounding tissues, specifically pulp tissue. In a 
study by  Qvest et al. in 1989, they showed that teeth restored with RC using different 
reducing-leakage methods cause increases in pulp reactions and inflammation/necrosis.
1
 
Studies that compare amalgam to resin-based composite restorations show that 
composites do have higher failure rates than that of amalgam.
2
 In a primary care setting, 
pulp breakdown and endodontic complications were four times more likely with 
composite restorations than with amalgam restorations.
2
 One of the components of RC 
that was found to leach was triethylene glycol dimethacrylate (TEGDMA). These 
monomers were found to leach either due to incomplete polymerization of the resin or  
mechanical or chemical degradation of the restoration.
3
  
TEGDMA is a small hydrophilic monomer (Figure 1). It forms approximately 30 
percent to 50 percent of almost all the resin-based composites. TEGDMA is added to 
improve viscosity and to make the RC more manageable clinically. These monomers can 
reach the pulp and can cause cell death either by necrosis or apoptosis. Apoptosis is a 
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programmed, energy dependent cell death which causes cells to shrink with no loss of the 
membrane integrity. In contrast, necrosis is an uncontrolled, pathological process that 
does not require energy and the cells swell and lose their membrane integrity.  The main 
difference between necrosis and apoptosis is that there are minimal inflammatory 
responses initiated in apoptosis.     
Different dental materials can affect pulp tissue and can even result in apoptosis 
and necrosis.  Although TEGDMA-induced apoptosis in primary human pulp has been 
reported,
4
 the exact molecular mechanisms and the signal transduction pathways through 
which it occurs are not clear. Therefore, the aim of this study was to determine which 
apoptotic proteins are involved in TEGDMA-induced apoptosis.  
 
PURPOSE OF THE STUDY 
The purpose of this study was to determine which apoptotic proteins (anti-
apoptotic proteins and pro-apoptotic proteins) are involved in TEGDMA-induced 
apoptosis in human pulp fibroblasts.  
 
HYPOTHESIS  
TEGDMA will increase the concentrations of pro-apoptotic proteins in the 
extrinsic pathway in human pulp fibroblasts.  
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Resin composites (RC) were introduced in the mid-sixties by R. L. Bowen.
5
 He 
prepared the monomer 2,2-bis[4-(2-hydroxy-3 methacryloyloxypropoxy) phenyl]propane 
(Bis GMA) from combining bisphenol A with glycidyl methacrylate and after that added 
diglycidyl ether of bisphenol. Bis-GMA, molecular weight (MW) 512,  is considered to 
be the backbone of RC.
5
 
To have a better understanding of RC, one should define RC in general and in 
dental terms. RC is defined as "three-dimensional combination of at least two chemically 
different materials with a distinct interface separating the components.”5 Fundamentally, 
dental RC are formed from three chemically-distinct materials or phases: 1) the organic 
phase or the matrix, 2) the disperse phase or the inorganic filler, and 3) the coupling 
phase with an organosilane agent that connects the disperse phase with the matrix.
6
 
The matrix of the RC is composed primarily of mono-, di- or tri-monomers. 
Manufacturers still focus on the traditional molecule Bis-GMA alone or in combination 
with urethan dimethacrylate (UDMA). These molecules represent around 20 percent (v/v) 
of the constituents of the RC. These molecules are highly viscous substances. The 
viscosity of water is approximately 1 mPa-s (23°C), while the viscosity of BisGMA is 
approximately 1,000,000 mPa-s (23°C). However to enhance the properties of RC and 
make them clinically manageable, diluents with lower viscosity are added such as 
TEGDMA. TEGDMA is a small (MW 286) hydrophilic molecule.
7
 TEGDMA’s viscosity 
is 10 mPa-s (23˚C), which makes TEGDMA one of the major diluents added to the Bis-
GMA. TEGDMA  actually composes around 30 percent to 50 percent of the RC.
6
  While 
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its addition enhances the clinical properties of the RC, other challenges are faced in 
regard to the biocompatibility of these RC. Due to incomplete polymerization and 
continuous degradation attributed either  to mechanical or chemical wear through the 
masticatory forces and salivary esterases, these monomers were found to leach into the 
surrounding tissues.
7
  
Unpolymerized TEGDMA is responsible for some of the cytotoxic effects of RC 
and dental adhesives on pulp and gingival fibroblasts.
8
 Walther et al.
9
 found that a key 
element in TEGDMA-induced apoptosis was the production of reactive oxygen species 
(ROS).
10
 This ROS production was found to be associated with reduced amounts of the 
natural ROS scavenger glutathion (GSH).
11
 It was found that TEGDMA plays a role in 
decreasing GSH levels, for example to 30 percent to 50 percent.
12, 13
 GSH is the most 
abundant non-protein thiol in eukaryotic cells.
14
 GSH plays an important role in 
protecting the cells from the damage caused by ROS. 
Despite the efforts to decrease the amounts of unpolymerized monomers 
remaining in the RC after polymerization, a percentage (1.5 percent to 5 percent) of the 
monomers remain unreacted and may leach.
12
 There are two factors that hinder the 
complete polymerization, especially when direct pulp capping is involved. These issues 
are oxygen and humidity, which are excessively present especially in the previously 
mentioned scenario (direct pulp capping).
15
 However, though this percentage is small, it 
is still enough to induce apoptosis in pulp fibroblasts.
8
  
According to a study conducted by Janke et al.
16
 in gingival fibroblasts, 
TEGDMA caused apoptotic cell death rather than necrotic cell death. Other dental 
materials that may also induce pulp apoptosis are used as pulp capping agents such as: 
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calcium hydroxide, zinc oxide eugenol cement, or 4-Methyl methacrylate–tri-n-
butylborane (4MMT).
17
  Necrosis can be a pulp cell reaction that occurs in response to 
different dental materials. Necrosis is defined as a passive irreversible catastrophic cell 
death that results when ATP is depleted to an incompatible level for cell survival. The 
depletion of ATP levels lead to malfunction of the ATP-dependent ion pump. This 
malfunction of the ATP-dependent ion pump leads to the activation of the so -called 
cytoplasmic death channel. Opening of the death channel causes cationic ions to leak into 
the cells, resulting in disruption in the colloidal osmotic pressure of the cell. This cationic 
entry and the increase in the colloidal osmotic forces cause the cell to swell and then 
rupture.
18
 Therefore, a main criterion of necrosis is the loss of cellular membrane 
integrity and induction of inflammation in the surrounding tissues. Inflammation results 
from the release of the cellular content and pro-inflammatory products of the dying 
cells.
19
 Pulp necrosis and inflammation extends through the apical foramen to the 
surrounding bone and periodontium resulting in periapical inflammation.
20
 In contrast, 
apoptosis is defined as a programmed suicidal death that requires energy for execution. 
The main differences between apoptotic cell death and necrosis is that in necrosis the 
cells are unable to maintain their electrochemical potentials, which results in the rupture 
of cell membrane. When a cellular membrane ruptures, the cell contents are released to 
the surrounding tissue and cause the second important difference, which is the initiation 
of inflammatory response. In apoptosis, cells modify their surface proteins so they can be 
phagocytized by macrophages.
21
 Based on that, apoptosis causes a lower level of  
inflammatory responses than does necrosis.
22
 This could be important in evaluating the 
biocompatibility of a material.
22
 It is important to realize that apoptosis is induced at 
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lower concentrations, while higher concentrations cause necrosis.
18
 TEGDMA was 
shown to cause an increase of necrotic cells at concentrations higher than 3 mM, while at 
concentrations lower than that, apoptotic cells were dominant.
4
 Since the concentration of 
TEGDMA used for this study is less than 3mM, the focus is going to be on apoptosis 
rather than necrosis. The main differences between apoptosis and necrosis are noted in 
Table I.  
There are two major pathways for apoptosis, extrinsic and intrinsic pathways. The 
extrinsic pathway occurs via binding of cell surface death receptors to their specific 
ligands. These transmembrane receptors belong to the tumor necrosis factor receptor 
(TNFR) superfamily and include Fas, TRAIL (TNF-related apoptosis inducing ligand) 
receptor, and TNFR. Upon activation of these transmembrane receptors by their 
corresponding ligands, caspase 8 is activated. Caspase 8 activates caspase 3,  which 
mediates apoptosis (Figure 2).
23
 The intrinsic pathway occurs from activating signals 
from within the cells due to intense cellular stresses such as DNA damage, growth factor, 
severe deprivation, and oxidative stress (ROS production) as shown in Figure 2.
24
 The 
intrinsic pathway depends on the balance between pro-apototic and anti-apoptotic 
proteins of the BCL-2 superfamily (Table II). The balance between the pro-apoptotic and 
anti-apoptotic determines if the cell lives or die.
25
 Any shift in balance changes  
mitochondrial permeabilty.
26, 27
 Mitochondrial permeability increases when the balance 
shifts toward the pro-apoptotic proteins and allows SMAC (second mitochondria-derived 
activator of caspases), HtrA (high temperature requirement protein A) and then 
cytochrome c to be translocated from the mitochondria to the cytosol. SMAC activates 
apoptosis through binding directly to inhibitory apoptotic family (IAP) family members. 
9 
 
 
 
The release of cytochrome c plays a critical role in mammalian apoptosis.
26
 Cytochrome 
c binds to apoptotic protease activating factor 1 (APAF-1) to form a multiprotein 
structure called apoptosome. The primary function of the apoptosome is the activation of 
caspase 9.
28, 29
 Caspase 3 is then activated by caspase 9, which causes oligonucleosomal 
DNA fragmentation to occur (i.e., apoptosis) (Figure 2).
30
  
Both pathways result in the activation of the caspases. Caspases play a crucial role 
in the induction of apoptosis, and their inhibition can cause failure in apoptosis even if 
the mitochondrial cytochrome c was released.
31
 Caspases are intracellular proteases that 
execute the apoptotic processes through the destruction of cellular proteins that are vital 
for the cells, which ultimately results in cell death. Caspases are usually kept in an 
inactivated form by IAP (inhibitors of apoptosis) proteins such as IAP 1 and IAP2, as 
well as by Survivin. These inhibitory effects can either be achieved directly by binding or 
indirectly through suppression of the caspase initiators.
32
 Some caspases can be initiators 
(caspase 2, caspase 8,  and caspase 9) that are activated through signaling pathways, 
which in turn activate the effector caspases (caspase 3, caspase 6,  and caspase 7) that 
carry out the apoptotic processes.
32
 Figure 3 illustrates the inhibitory roles of the IAPs on 
the caspases (adapted from Ashkenazi, 2002). 
Caspase 8 plays a major role in initiating the extrinsic pathway.  Procaspase 8 
engages the death effecter domains (DED) to form the death inducer signaling complexes 
(DISC). This complex is then ligated to one of the tissue necrotizing factor receptors 
(TNFR). These interactions cause several molecules of procaspase 8 to be in close 
proximity to other molecules of procaspase 8, and this proximity leads to their activation 
through a mechanism called auto-proteolysis as shown in Figure 4. In most cell types, the 
10 
 
 
 
activation of caspase 8 through the activation of the TRAIL receptors is not enough to 
fully induce apoptosis. In these cells, caspase 8 activates the Bcl-2 pro-apoptotic protein 
Bid, which in turn activates the intrinsic pathway.
30
 Bid is an intermediary proapoptotic 
protein that connects the extrinsic and the intrinsic pathways (Figure 2).
33, 34
 
A study conducted by Spanguolo et al.
4
 showed TEGDMA-induced apoptosis 
rather than necrosis in pulp fibroblasts. This TEGDMA- induced apoptosis was time- and 
concentration-dependent.
4
 Noda et al.
35
 were able to calculate the amount of TEGDMA 
leaching from RC to the pulp. They noted that the concentration of TEGDMA in many 
composites is approximately 30 percent to 50 percent. Pure TEGDMA has a 
concentration of 3.8 mol/L. Therefore, the molar concentration in composites is slightly 
less than 2 mol/L.
36
 The dilution factor of TEGDMA across 0.5 mM of dentin was 
determined to be 500.
36
  Based on that, the amount of TEGDMA that reaches pulp 
fibroblasts is around 4 mM/L.
35
 Small concentrations of TEGDMA in the lower 
millimolar range are clinically significant
35
 and may cause pulp tissue injury.
37
 Pulp is 
connective tissue that responds to TEGDMA leaching. The most common response of the 
pulp is the formation of tertiary dentin in an attempt to preserve the integrity and 
structure of the tissue.
38
 Another response is the decrease in the volume of the pulp 
chamber upon the induction of apoptosis.
39
 
One way that TEGDMA exposure leads to apoptosis could be through oxidative 
stress. TEGDMA causes a drastic depletion of glutathione (GSH) resulting in oxidative 
stress conditions.
40
 GSH is the most abundant non-protein thiol in eukaryotic cells.
14
 
GSH plays an important role in antioxidant defense.
14
The depletion of GSH leads to an 
excessive production of reactive oxygen species (ROS) in the cells. ROS formation 
11 
 
 
 
results in the release of cytochrome c from the mitochondria. Cytochrome c then activates 
the caspases, which leads to apoptosis. 
Although TEGDMA-induced apoptosis in primary human pulp has been 
reported,
4
 the exact molecular mechanisms and the signal transduction pathways through 
which apoptosis occurs are not clear. Therefore, the aim of this study was to determine 
which apoptotic proteins are altered in TEGDMA-induced apoptosis.  
12 
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CELL CULTURE 
Human pulp tissues were obtained from healthy impacted wisdom teeth. The use 
of the teeth was approved by Indiana University-Purdue University of Indianapolis 
Review Board. The pulp tissues were removed from the pulp cavities using tweezers after 
cutting the teeth in half using a high-speed hand piece with  a 330 fissure bur and water 
spray. The fissure bur was changed regularly to eliminate the friction heat that is 
produced after it becomes dull to avoid heat damage to the pulp tissues. The pulp tissues 
were then minced with a blade into several fragments approximately (1 mm x 1mm x 2 
mm in size). These fragments were then placed in 100-mm culture dishes and air dried, 
and then Dulbecco’s Modified Essential Media (DMEM) was added, supplemented with 
10-percent fetal bovine serum, 4 mM L-glutamine, 2.5 g/mL fungizone, 100 unit/mL 
penicillin, and 50 g/mL gentamicin.
41
 The tissues were maintained at 37˚C in a 
humidified atmosphere of 5-percent CO2. The pulp cells that grew out from the tissue 
fragments were then allowed to reach confluence (Figure 5). Confluent cells were 
detached with 0.25-percent trypsin and 0.05-percent ethylenediaminetetraacetic acid, and 
subcultured as needed. Cells were used at passages 3 through 8.  
 
MEASUREMENT OF TEGDMA CYTOTOXICITY ON  
HUMAN PULP FIBROBLASTS (HPFs) BY LACTATE 
DEHYDROGENASE (LDH) ASSAYS 
 
Cellular membrane integrity was monitored using the permeability assay based on 
the determination of the release of LDH from cells into the media.  The Cytotoxicity 
14 
 
 
 
Detection Kit
PLUS 
(Roche Applied Science, Mannheim, Germany), which measures the 
conversion of tetrazolium salt into a red formazan product, was used as described 
previously.
42
  Cells were treated with 0.125 mM, 0.25 mM, 0.50 mM, 0.75 mM, and 1.00 
mM of TEGDMA in 100-mm incubation dish with serum-free DMEM for 24 hrs. The 
high control (total cell death) was generated by adding 1.9 ml of serum-free DMEM and 
100-µl lysis solution to the control cells as described by the manufacturer after 24 hours, 
which gave the maximum release of LDH.  The low control consisted of serum-free 
DMEM from the untreated control cells after 24 hours and gave the minimal release of 
LDH.  Serum-free DMEM without HPFs was utilized as the background level of the 
assay.  After 24 hours, media from each of the wells were transferred to a 96-well plate 
and 100 µl of reconstituted mix as per the manufacturer (Roche) was added to each well 
and the plates incubated for 15 minutes at room temperature. Absorbance was recorded at 
490 nm in a microplate reader (Titertek, Multiskan MCC, Flow Laboratories, McLean, 
VA).  The experiments were repeated five times and the mean value calculated.  The 
percentage release of LDH from the treated cells was calculated by comparing it to the 
maximum release of LDH.  To determine the cytotoxicity, the absorbance values of the 
background were subtracted from those of the experimented samples, and the cytotoxicity 
was calculated by the following equation: 
Cytotoxicity (%) = (experiment value-low control)/ (high control–low control) 
×100% 
 
CELL TREATMENT WITH TEGDMA 
Sub-confluent layers of HPFs at passages 3 through 8 were utilized for the 
RayBio Antibody Apoptosis kit (Norcross, GA). HPFs (2 x 10
5 
cells/100 mm dish) were 
15 
 
 
 
incubated with or without 0.25 mM TEGDMA for 6 and 24 hours. 
 
 
PREPARATION OF CELL LYSATES  
Cell lysates were prepared as per the manufacturer at (www.raybiotech.com). 
Briefly, cells were rinsed twice with cold phosphate-buffered saline (PBS) and the 
remaining PBS removed before adding the lysis buffer. The cells were then solubilized at 
2x10
7
cells/ml in lysis buffer containing protease inhibitor cocktail as per the 
manufacturer. The cells were then pipetted up and down, and the lysate rocked gently at 4 
°C for 30 minutes. The extracts were transferred to microfuge tubes and centrifuged at 
14,000 x g for 10 minutes and then the supernatant was collected (cell lysate). 
The protein concentrations of the cell lysates were determined using Bio-Rad 
Protein Assay kit (Hercules,CA). All the lysates were diluted at least five-fold with 
blocking buffer to the same protein concentration of 200 µg/ ml per the manufacturer.  
 
THE RAY BIOTECH APOPTOSIS ARRAY 
A Human Apoptosis Antibody Array kit was purchased from Ray Biotech 
(Norcross, GA). The relative level of 43 apoptosis-related proteins in the cell lysates were 
detected with the RayBio® Human Apoptosis Antibody Array kit according to 
manufacturer’s instructions; the experiment was repeated four times. The arrays were 
analyzed with a Gel-Doc XR imaging system (Bio-Rad, Hercules, CA). Quantity one 
analysis software (Bio-Rad, Hercules, CA) was used to analyze the images obtained. 
Measurements of the protein images were repeated three times. 
Briefly, the treated or untreated cell lysates were added to the antibody array 
membranes. After extensive washing, the membranes were incubated with a cocktail of 
16 
 
 
 
biotin-conjugated anti-apoptotic protein antibodies. After incubation with horseradish 
peroxidase (HRP)-streptavidin, the signals were visualized by chemiluminescence. 
 
STATISTICAL ANALYSES 
Data were reported as mean± SD (standard deviation). The sample size was three 
samples for each group (0.25 mM and the control). The density of the proteins was 
measured in three different arrays. Since each sample was measured multiple times, the 
density of each protein expression was modeled using a repeated measures analysis of 
variance (ANOVA) model. The ANOVA model had a fixed effect for each group, which 
allowed for estimation of mean density; a random run effect, which allowed for correlation of 
measurements from the same run; and a random sample effect, which allowed for the 
correlation of measurements from the same sample. Pair-wise comparisons between the 6 
treatment combinations were performed using Tukey's method to control the overall 
significance level of the comparisons at 5 percent. 
17 
 
 
 
 
 
 
 
 
 
                                                                           
 
 
 
 
 
RESULTS 
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CYTOTOXICITY RESULTS (LDH) 
The LDH assay was repeated five times and the averages with standard deviation 
(SD) were determined. The p-values were then calculated; significance was established 
where p < 0.05. The highest non-toxic concentration of TEGDMA was determined based 
on the LDH assays. This concentration was the highest concentration that was not 
significantly higher than that of the control in regard to cytotoxicity. TEGDMA at 0.50, 
0.75, and 1.00 mM were statistically higher than that of the control (Table III).  The 
concentration that was chosen for the human apoptosis antibody arrays was 0.25 mM 
TEGDMA, which was not significantly different than the control (p=.806) 
 
RAYBIO APOPTOSIS ARRAY RESULTS 
The relative expression of apoptotic proteins using the RayBio human apoptosis 
antibody array kit that were significantly higher at 6 hours were: B cell lymphoma-w 
(Bcl-w) (p=.010); BH3-interacting domain death agonist (BID) (p= .001); (Bim) 
(p=.009); heat shock protein 27 (HSP 27) (p= .022); HSP 60 ( p= .007); HSP 70 (p= 
.010);  heat shock-inducible protein (HTRA) (p=.001); Insulin like growth factor binding 
protein-1 (IGFBP-1) (p= .004); IGFBP-2 (p= .011); P21(p= .016); (P27) (p= .015); 
second mitochondria-derived activator of caspases (SMAC) (p= .018) (Figure 7). All of 
these were pro-apoptotic proteins.  
The only anti-apoptotic proteins that were significantly increased compared with 
the control at 6 hours were Survivin ( p=.015); IGFBP-5 (p= .012); and Livin (p= .006). 
The pro-apoptotic proteins that significantly decreased compared with the control at 6 
19 
 
 
 
hours were tumor necrosis factor ligand superfamily member 6 (FASL) (p=.010); TNF-β 
(p= .046); and TRAIL-r2 (p=.003).  
            However at 24 hours, more pro-apoptotic proteins had significant increases 
compared to the control than at 6 hours. These were Bad (p= 0.021); Bax (p= 0.027); Bcl-
2 (p= 0.005); Bcl-w (p= 0.017); Bid (p= 0.005); Bim (p= 0.031); Caspase 3 (p= 0.028); 
Caspase 8 (p= .028); CD40L (p= 0.006); Cytochrome c (Cyto c) (p=.001); IGFBP-5 (p= 
0.020); IGFBP-6 (p= 0.005); cyclin-dependent kinase inhibitor 1B (p27, kip1) (p= 
0.009); P27 (p= 0.006); serum tumor necrosis factor receptor 1 (sTNF-R1) (p= 0.001); 
sTNF-r2 (p= 0.004); Tissue necrotizing factor –α (TNF-α) (p= 0.001); TNF-β (p= 0.003); 
TNF-related apoptosis-inducing ligand receptor 1 (TRAILR 1) (p= 0.016); TRAILR 2 
(p= 0.028); TRAILR 3 (p= 0.039), and TRAILR 4 (p= 0.010). The anti-apoptotic proteins 
that had greater relative expression significant from the control were (Bcl-2) (p= 0.017); 
Livin (p= 0.001); Survivin (p= 0.001); IGF-II (p= 0.001).   
The only anti-apoptotic protein that significantly decreased was HSP 70 (p= 
0.034).  There were no pro-apoptotic proteins that were significantly decreased in their 
relative expression at 24 hours compared to the controls. 
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TABLES AND FIGURES 
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TABLE I 
  Apoptosis (programmed cell death) and necrosis (pathologic cell death) 
 
Apoptosis Necrosis 
Controlled process, physiological 
stimuli 
Uncontrolled process, pathological 
stimuli 
Energy dependent (ATP required) No energy required (passive) 
Cells shrink (apoptotic bodies) Cells swell (leading to cell lysis) 
No loss of membrane integrity Membrane integrity lost 
Non-inflammatory Inflammatory 
Nuclear fragmentation Nuclear dissolution 
Individual or small cell groups Large cell groups (organ segments) 
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TABLE II 
                                            BCL-2 superfamily
43
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TABLE III 
                                      LDH results and p-values 
Concentration of TEGDMA Cytotoxicity±SD P-value 
NC (negative control, 0 mM) 0±0.00  
0.13 Mm -0.74±0.02 1.00 
0.25 mM 1.46±0.01 .806 
0.50 mM 4.96±0.02 .004٭ 
0.75 mM 10.7±0.02 .000٭ 
1.00 Mm 20.6±0.01 .000٭ 
 
٭ Denotes statistical significance (p-value < 0.05). 
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TABLE V 
   Relative expressions of apoptotic proteins and p-values 
 
  
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
. 
 
* Denotes statistical significance (p < 0.05). 
 
Apoptotic 
protein 6hrs ± SD 
 
P value 24 hrs ± SD 
 
P value 
Bad  1.65 ± 0.71 .116 1.57 ± 0.37 .021* 
Bax  1.29 ± 0.38 .184 1.20 ± 0.17 .027* 
Bcl-2 2.24 ± 0.75 .046 1.59 ± 0.34 .005* 
Bcl-w 2.11 ± 0.41 .010* 1.20 ± 0.12 .017* 
Bid  2.08 ± 0.53 .001* 1.17 ± 0.12 .005* 
Bim  1.63 ± 0.54 .009* 1.21 ± 0.18 .031* 
Caspase3  1.41 ± 0.48 .344 1.54 ± 0.28 .028* 
Caspase8  1.52 ± 0.54 .557 1.59 ± 0.30 .028* 
CD40  1.19 ± 0.46 .510 0.83 ± 0.45 .545 
CD40L  0.74 ± 0.38 .124 1.15 ± 0.07 .006* 
cIAP-2  1.23 ± 0.17 .905 1.15 ± 0.29 .335 
Cyto c  0.88 ± 0.20 .174 1.21 ± 0.05 .001* 
DR6   0.89 ± 0.24 .303 1.02 ± 0.10 .724 
Fas  1.02 ± 0.21 .792 1.12 ± 0.13 .108 
Fasl   0.71 ± 0.22 .010* 1.12 ± 0.11 .072 
HSP27  1.91 ± 0.35 .022* 1.00 ±0.08 .966 
HSP60  1.20 ± 0.10 .007* 0.95 ± 0.13 .355 
HSP70  1.06 ± 0.05 .010* 0.87 ± 0.13 .034* 
HTRA  1.24 ± 0.23 .020* 1.16 ± 0.13 .101 
IGF-I  13.22 ± 5.74 .021* 0.92 ± 0.06 .147 
IGF-II 0.82 ± 0.72 .681 2.91 ± 0.41 .001* 
IGFBP-1 1.61 ± 0.47 .004* 1.47 ± 0.49 .104 
IGFBP-2 1.53 ± 0.29 .011* 1.13 ± 0.20 .100 
IGFBP-3  1.63 ± 0.54 .113 1.11 ± 0.19 .288 
IGFBP-4  1.89 ± 1.14 .247 1.01 ± 0.25 .963 
IGFBP-5  1.33 ± 0.19 .012* 1.23 ± 0.14 .020* 
IGFBP-6  1.60 ± 0.68 .200 1.41 ± 0.02 .005* 
IGF-1sr  0.97 ± 0.03 .214 1.55± 0.41 .036 
Livin  2.74± 0.83 .006* 1.61 ± 0.20 .001* 
P21  1.14± 0.12 .016* 1.15 ± 0.08 .009* 
P27  2.01± 0.43 .015* 1.27 ± 0.17 .006* 
P53  0.97 ± 0.18 .671 1.31 ± 0.15 .070 
SMAC 1.32 ± 0.20 .018* 1.06 ± 0.12 .258 
Survivin 1.29 ± 0.12 .015* 1.21 ± 0.10 .001* 
sTNF-r1  0.55 ± 0.48 .183 1.62 ± 0.02 .001* 
sTNF-r2  1.57 ± 0.39 .063 2.24 ± 0.37 .004* 
TNF-alpha 1.01 ± 0.08 .242 2.25 ± 0.01 .001* 
TNF-beta  0.57 ± 0.20 .046* 1.53 ± 0.18 .003* 
TRAIL- R1  1.28 ± 0.37 .257 1.42 ± 0.06 .016* 
TRAIL- R2  0.78 ± 0.14 .003* 1.20 ± 0.07 .028* 
TRAIL- R3  1.00 ± 0.20 .944 1.64 ± 0.36 .039* 
 TRAIL- R4 1.39 ± 0.35 .068 1.31 ± 0.13 .010* 
 XIAP  1.15 ± 0.24 .259 1.15 ±0.14 .074 
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FIGURE 1. Triethylene glycol dimethacrylate (TEGDMA). 
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                           FIGURE 2. Extrinsic and intrinsic pathway. 
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http://www.biooncology.com/research/apoptosis/pathways/caspase-cascade/index.html 
 
FIGURE 3. IAPs and caspase inhibition. 
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FIGURE 4. Extrinsic pathway.
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                         FIGURE 5.  Human pulp fibroblasts growing out of pulp tissue. 
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                                                                    TEGDMA  
FIGURE 6. Concentration of TEGDMA versus percent of cytotoxicity after 24-hour 
exposure at various concentrations. *Denotes statistical significance (p-
value < 0.05). HC denotes high control (maximum-released LDH/total cell 
death).  
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                  FIGURE 7. Induced apoptotic proteins at 6 hours. 
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                       FIGURE 8. Induced apoptotic at 24 hours. 
 
 
 
 
 
 
 
34 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
DISCUSSION 
35 
 
 
 
 
 
 
The biological effects of TEGDMA on apoptosis of pulp fibroblasts were 
examined. LDH assay was used to measure cell cytotoxicity. The rationale for using the 
LDH assays was to verify the concentration at which necrosis starts and to hopefully 
ensure the presence of apoptotic cells rather than necrotic. The results of this current 
study showed that TEGDMA had statistically significant cytotoxic effects at 0.5 mM and 
above. Therefore, 0.25 mM of  TEGDMA  was used in this study and is clinically 
relevant as discussed previously.
35
  
The results of this study demonstrated that TEGDMA increases the expression of 
the multiple pro-apoptotic proteins. There were statistically significant increases in the 
expression of these proteins after 6 h and 24 h when compared with the control. The 
extrinsic apoptotic pathway is activated through the activation of the transmembrane 
receptors of the TNF family. Members of the TNF family include TNFR 1 and 2, Fas, 
death receptor (DR) 6, CD40, and TRAIL-R 1-4, which bind to their corresponding 
ligands (i.e., TNF-α, TNF-β, fasL, CD40L, and TRAIL, respectively). This study showed 
that there were statistically significant increases in TNF-α and TNF-β after 24 h (Figure 
8). TRAIL-R 1 and 2 contain death domains, which mean they are able to induce 
apoptosis by activating caspase 8, whereas TRAIL-R 2-4 are considered to be 
antagonistic decoys and do not induce death signals.
45
 This study showed statistically 
significant increases in all TRAIL receptors after 24 hours (Figure 8). Fas increased 
slightly when compared with the control; at 24 h, it was not statistically significant. Fas L 
36 
 
 
 
at 24 h showed a slight increase that was not statistically significant; however, it showed 
a statistically significant decrease at 6 hours (Figure 7). This decrease in the expression of 
Fas L could be explained by the presence of anti-apoptotic proteins that could down- 
regulate it.
46
      
Iwama K et al.
47
 reported that excessive ROS production due to arsenic trioxide 
(ATO) toxicity resulted in changing membrane permeability.  ATO rapidly induced 
TRAIL and then activates caspase 8, which resulted in the phosphorylation of 
Bid.
47
TEGDMA treatment leads to the production of ROS is documented in the 
literature.
48
 This study showed significant increases of all TRAIL receptors at 24 hours 
(Figure 8), which is in line with the previous study.
47
 Activation of the extrinsic pathway 
will result in caspase activation, specifically caspase 8. The process then is induced by 
two parallel pathways. The first pathway is through the cleavage and activation of 
caspase 3 and the second is created when the TRAIL receptors activates the extracellular 
pathway. In that case the intrinsic pathway (mitochondrial pathway) is activated after the 
activation of the pro-apoptotic protein Bid by caspase 8 (Figure 2).
27, 29
 In this study,  the 
caspase pathway was activated, because there were statistically significant increases in 
both caspase 8 and 3 after 24 h, which indicated the extrinsic pathway was activated 
(Figure 7). Bid had increased and was statistically significant after 24 h, which also  
indicated that the mitochondrial pathway had been activated. Upon Bid activation, Bcl-2 
family proteins are activated. The Bcl-2 family includes both pro- and anti-apoptotic 
proteins. Some pro-apoptotic proteins that were induced were Bim, Bax, and Bad. When 
Bad and Bim are phosphorelated, they are sequestered and enter into the mitochondria to 
cause the release of cytochrome c, SMAC and HtrA. Bad also binds to anti-apoptotic 
37 
 
 
 
proteins (Bcl-2 and Bcl-w) and prevents their inhibitory effects on apoptosis.
27, 49
  The 
interactions between the pro- and anti-apoptotic proteins results in no inhibition of 
apoptosis and thus causes depolarization of the mitochondria. Depolarization of the 
mitochondria results in increases in the permeability of their membranes, thus releasing 
more pro-apoptotic factors like SMAC, HtrA and cytochrome c. This study showed 
significant increases in some of the Bcl-2 family members that are involved in the 
mitochondrial pathway. Bid and Bim (pro-apoptotic proteins of the Bcl-2 family) were 
both significantly increased at 6 h (Figure 8) and 24 h (Figure 7). Bcl-w (anti-apoptotic 
protein) was also significantly increased at 6 h and 24 h. SMAC and HtrA are two pro-
apoptotic proteins that are released upon the activation of the intrinsic pathway. These 
two pro-apoptotic proteins will promote apoptosis through binding to the cIAP anti-
apoptotic protein preventing its inhibitory effects on apoptosis.
50
 SMAC and HtrA were 
increased significantly at 6 h (Figure 8) and increased slightly at 24 h, but was not 
significant.  
Another important pro-apoptotic protein that is released from the mitochondria 
upon the activation of the intrinsic pathway is cytochrome c. Cytochrome c activates 
caspase 9 and then caspase 9 activates caspase 3.  Cytochrome c was statistically 
significantly increased compared with the control at 24 h (Figure 7).
44
 
Members of the heat shock protein (HSP) family are over-expressed under 
biological stress such as heat or when treated with toxic materials. Their function in 
general is to prevent cellular protein aggregation and to increase levels of reduced 
glutathione to protect the cell from reactive oxygen species (ROS). 
51
 HSP 27 and 70 are 
anti-apoptotic proteins, while HSP 60 is a pro-apoptotic protein. The current study agrees 
38 
 
 
 
with  Noda et al.
35
 They showed that TEGDMA inhibits the phosphorylation of HSPs, 
thereby decreasing their levels.
35, 51
This study showed there was activation of HSP 70 and 
its increase was statistically significant at 6 h (Figure 8), but its level at 24 h was 
decreased significantly (Figure 7), which indicated that the anti-apoptotic effects of HSP 
70 was counteracted. As for HSP 60, there was a slight decrease at 24 h, yet it was not 
significant statistically. HSP 27 was unaltered.  
IGF-1 plays an important role in cell survival pathway and inhibiting apoptosis. 
IGF-1 activation causes induction of two major signaling pathways:  the 
phosphatidylinositol-triphosphate kinase/AKTransforming (PI3K/AKT) pathway and the 
mitogen-activated protein kinase (MAPK) pathway.
52
 This leads to lower concentrations 
of pro-apoptotic proteins like Bax and Bad, but increases the expression of anti-apoptotic 
proteins like Bcl-w. These pathways tend to inhibit caspases specifically caspase-3.
52
 
Spagnuolo et al.
4
 showed that AKT is a main target in TEGDMA-induced apoptosis. This 
study showed significantly higher levels of IGF-1, especially after 6 h. These results are 
in an agreement with Spagnuolo et al., since IGF-1 activates the PI3K/AKT pathway.
4
 
However, IGF-1 expression at 24 h slightly decreased. One of the signs of apoptosis is 
decrease in IGF levels. 
Insulin-like growth factor-binding proteins (IGFBP) had been described to have 
both pro- and anti-apoptotic effects. The effects of IGFBP-5 are variable depending on 
the tissue and cell type.
53, 54
 IGFBP 5 was shown to be anti-apoptotic in gingival 
fibroblasts. However, in the current study, the increase of IGFBP-5 at 24 hours may have 
led to activation of caspase 3. The increase of caspase 3 is an important sign of apoptosis 
activation.
30
 This study also showed elevated levels of IGFBP 6. IGFBP-6 is associated 
39 
 
 
 
with the apoptotic pathway c-jun N-terminal kinase (JNK) activation and the inhibition of 
nuclear factor kappa B (NFkappaB). Both these pathways were shown by Samuelsen et 
al.
48
 to be involved in the TEGDMA-induced apoptosis. This study showed significant 
increases in the expression of IGFBP-6 in comparison with the control at 24 h. 
There are several reports about TEGDMA causing genotoxicity and cell-cycle 
delay.
55
 The p21 and p27 are cell cycle regulators. The tumor suppressor protein p53 is 
the main regulator of p21. Krifta et al.
56
 showed that there was a slight increase in p53 
expression, while there was a noticeable increase in the expression of p21. This study 
agrees with their findings in that significant increases in p21 occurred at 6 h and 24 h. 
While p53 showed slightly elevated levels at 24 h only and was not significant.  
IAP proteins are caspase inhibitor proteins. Survivin, Livin, XIAP, and cIAP are 
members of this family. It has been shown that XIAP  has high affinity for caspase 3 and 
tries to inhibit apoptosis once it started.
46
 SMAC and HtrA (mitochondrial pro-apoptotic 
proteins) are known to bind to these inhibitory apoptotic proteins and inhibit their 
functions.
46
  Survivin and Livin significantly increased at 6 h and 24 h. However, these 
increases were not enough to inhibit apoptosis. Caspase 8 and caspase 3 were both 
activated at 24 h, indicating the apoptotic process was still continuing.
46
  
This current study showed that TEGDMA-activated apoptosis within 24 h. The 
extrinsic pathway at 24 h is clearly activated and was activated after the activation of 
members of the TNFR family. The activation of the intrinsic pathway started at 6 h, but it 
was amplified at 24 h. Bax and cytochrome c, are essential pro-apoptotic proteins for the 
intrinsic pathway. Bax and cytochrome c were not activated until the extrinsic pathway 
40 
 
 
 
was also activated. Both pathways play a role in inducing apoptosis in TEGDMA-treated 
HPFs.  
 
41 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
SUMMARY AND CONCLUSION 
 
42 
 
 
 
 
 
 
The results of this study showed statistically significant increases of multiple 
examined pro-apoptotic proteins. The anti-apoptotic proteins were also altered. Most pro-
apoptotic proteins involved in the intrinsic (mitochondrial) pathway were significantly 
increased after 6 h and 24 h. Numerous pro-apoptotic proteins of the extrinsic pathway 
were activated at 24 h. The activation of these pro-apoptotic proteins in the extrinsic 
pathway amplified the intrinsic pro-apoptotic proteins at 24 h. More pro-apoptotic 
proteins in the intrinsic pathway were activated at 24 h than at 6 h. TEGDMA has effects 
on both the extrinsic and intrinsic apoptotic pathways. The results of this study showed 
involvement of some proteins involved in the TEGDMA- induced apoptosis that 
coincides with the aim of this study. More research is still needed to elucidate the net 
effects of this apoptotic process on the pulp tissue and to find more clinically relevant 
ways to stop or even reverse this process if possible.     
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TEGDMA INDUCTION OF APOPTOTIC PROTEINS 
 IN PULP FIBROBLASTS 
 
 
 
 
 
by 
Ghada Batarseh 
 
Indiana University School of Dentistry 
Indianapolis, Indiana 
 
Monomers like triethylene glycol dimethacrylate (TEGDMA) leach from dental 
composites and adhesives due to incomplete polymerization or polymer degradation. The 
release of these monomers causes a variety of reactions that can lead to cell death. This 
death can be either necrotic, which is characterized mainly by inflammation and injury to 
the surrounding tissues, or apoptotic, which elicits little inflammatory responses, if any at 
all. TEGDMA-induced apoptosis in human pulp has been reported recently. However, the 
molecular mechanisms and the apoptotic (pro and anti) proteins involved in this process 
remain unclear.  
The objective of this study was to determine the apoptotic proteins expressed or 
51 
 
 
 
suppressed during TEGDMA-induced apoptosis. Human pulp fibroblasts (HPFs) were 
incubated for 24 hours with different TEGDMA concentrations (0.125-1.0 mM). 
Cytotoxicity was determined using the cytotoxicity Detection Kit
PLUS
 (Roche Applied 
Science, Mannheim, Germany). TEGDMA was shown to cause cell cytotoxicity at 
concentrations of 0.50 mM and up. The highest concentration with no significant 
cytotoxicity was used. Cells were incubated with or without 0.25 mM TEGDMA for 6 h 
and 24 h. Cell lysates were then prepared and the protein concentrations determined using 
the Bradford protein assay. A Human Apoptosis Array kit (Bio-Rad Hercules, CA ) was 
utilized to detect the relative levels of 43 apoptotic proteins. The results of this study 
showed statistically significant increases of multiple examined pro-apoptotic proteins. 
The anti-apoptotic proteins were also altered. Pro-apoptotic proteins involved in the 
intrinsic and extrinsic apoptotic pathways were increased significantly. The results 
indicated that TEGDMA has effects on both the extrinsic and intrinsic apoptotic 
pathways.     
  
 
 
 
 
 
 
 
 
 
 
 
 
CURRICULUM VITAE 
 
 
 
  
 
 
 
Ghada Batarseh 
 
 
1994 DDS, with a major in General Dentistry,  
Jordan University, Amman   
 
1994 to 1996                        
 
Private practice in General Dentistry with 
Dr. Soleiman Ayyoub, Irbid, Jordan 
 
1996 Dental assistant in Kaiser Permanante, 
Portland, OR 
 
2007 Completed hands-on course in Restorative 
Dentistry at the Dougan Institute in 
Newport, CA 
 
2007 Expanded-duty dental assistant with Dr. 
Bob Taylor, Carmel, IN 
 
2009 Recipient, Richard J. Schnell Memorial 
Scholarship 
 
2010 Hands-on course in Endodontics at UCLA 
School of Dentistry, Los Angeles, CA 
 
2010 to 2011 
 
 
2011 
Bench instructor, Indiana University 
School of Dentistry, Indianapolis, IN 
 
MSD, Indiana University School of 
Dentistry, Indianapolis, IN 
 
